| Baseline (n = 36) | Week 12 (n = 36) | Week 24 (n = 36) | 1 year (n = 36) |
---|---|---|---|---|
Age, median (range) years | 54 (33-79) | Â | Â | Â |
% female | 77% | Â | Â | Â |
Disease duration, median (range) years | 9 (2-33) | Â | Â | Â |
RF positive | 36 | |||
ACPA positive | 28 | |||
RF/ACPA positive | 28 | Â | ||
 | mean ± SEM |  |  |  |
DAS28 score | 5.2 ± 0.3 | 3.3 ± 0.3ψ | 2.7 ± 0.2ψ | 1.9 ± 0.2ψ |
CRP, mg/dl | 0.9 ± 0.1 | 0.14 ± 0.06ψ | 0.09 ± 0.03ψ | 0.06 ± 0.02ψ |
ESR, mm/hour | 32.1 ± 3.4 | 9.8 ± 1.6ψ | 7.2 ± 0.9ψ | 5.6 ± 0.8ψ |
Patient’s VAS | 58.3 ± 4.4 | 48.6 ± 4.8ψ | 34.8 ± 5.4ψ | 21.5 ± 4.8ψ |
IgA-RF U/ml | 122.3 ± 33.3 | 99.9 ± 26.3ψ | 63.3 ± 19.8ψ | - |
IgA total U/ml | 265.4 ± 20.8 | 237.2 ± 19.5ψ | 203.1 ± 18.9ψ | - |